Abstract:Introduction Gene‐corrected autologous cells provide one avenue for treating respiratory diseases, such as Cystic Fibrosis and Primary Ciliary Dyskinesia that harbor an underlying genetic defect. Basal cells are critical stem cells in the airways with the capacity to generate all cells of the respiratory epithelium. Use of these cells is limited due to inherent difficulties in gene editing and expansion in vitro . Efficient generation of basal cells from iPSCs has the potential to generate enough cells for both autologous cell therapy and for in vitro disease modelling. Building on our airway differentiation protocol, we have derived a strategy for the specification, isolation and expansion of iPSC‐derived basal cells (iBasal) improving the efficiency of generating respiratory epithelium from iPSC. Methods iPSC are cultured using a modified differentiation protocol pushing the formation of lung progenitor cells sorted on day 17 of differentiation for CD47 hi CD26 lo cells. These cells express transcription factor NKx2.1 and can be cultured in defined serum‐free media in the absence of wnt signaling. Over 4 passages we evaluated; 1) expression of basal cell markers, 2) clonality by a limited dilution clonogenic assay and by spheroid formation and 3) stem cell potential in spheroid and air‐liquid interface differentiation assays. Gene expression was compared to that of primary endogenous basal cells by bulk and single cell RNAseq, and validated by qPCR. Results Under our defined culture conditions, iBasal can be derived from NKx2.1 expressing lung progenitor cells. They are clonogenic forming colonies expressing cytokeratin 5 (krt5), p63 and integrin alpha 6 (IGTA6), acquiring more mature basal cell marker, nerve growth factor receptor (NGFR), expression after passaging when cultured on NIH3T3‐J2 feeders or in defined media. iBasal have the capacity for differentiation into a functional, tight junction forming epithelium containing both mucus secreting and motile multiciliated cells at the air liquid interface. In addition, they can form and maintain as spheroids which can also differentiate to generate airway epithelial cells. iBasal can be passaged and maintain a basal cell phenotype similar to that of paired passaged human airway basal cells. Single cell sequence data on iBasal and paired primary and cultured basal cells will provide the ultimate validation of iBasal. Conclusion We have generated iBasal from four independent iPSC lines with functional properties akin to that of primary basal cells. iBasal, therefore, provide the opportunity to generate sufficient functional and gene‐corrected autologous basal cells to develop patient specific, high throughput screening platforms overcoming the current limitations. Support or Funding Information Cystic Fibrosis Foundation FIRTH17XX0, FIRTH15XX1, NIH:NHLBI R01 HL139828‐01, Hastings Foundation This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Understanding persistent airway obstruction in type 2 severe asthma using human induced pluripotent stem cells (iPSCs)

Modélisation de l'asthme sévère par la technologie des cellules humaines souches pluripotentes induites (hiPSC)

Development of a bronchial epithelium model innervated by sensory neurons from human induced pluripotent stem cells

Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells

Recapitulating idiopathic pulmonary fibrosis related alveolar epithelial dysfunction in a human iPSC‐derived air‐liquid interface model

Ex vivo modeling of human lung fibrogenesis and drug mode of action screens using single cell RNA-seq in precision-cut lung slices

Induced Pluripotent Stem Cell-Derived Basal Cells Provide A Novel Source of Multilineage Airway Epithelial Cells

In vitro platform to model the function of ionocytes in the human airway epithelium

Air-liquid interface (ALI) model of human bronchial epithelia cells for the investigation of asthma exacerbations

A common polymorphism in the Intelectin-1 gene influences mucus plugging in severe asthma

Lung Dysfunction in a Mouse Model of Inflammation is Dependent on T-cell-independent IL-13 Expression (54.18)

Modelling bronchial epithelial-fibroblast cross-talk in idiopathic pulmonary fibrosis (IPF) using a human-derived in vitro air liquid interface (ALI) culture

Benefits of bronchial epithelial repair by iPSCs in COPD

Effect of Transfected Induced Pluripotent Stem Cells with Decorin Gene on Control of Lung Remodeling in Allergic Asthma.

Combined cellular and gene therapy to treat primary ciliary dyskinesia

Bronchial mucosa produced by tissue engineering: a new tool to study cellular interactions in asthma

Inflammation‐induced loss of CFTR‐expressing airway ionocytes in non‐eosinophilic asthma

Co-culture of Human AT2 Cells with Fibroblasts Reveals a MUC5B Phenotype: Insights from an Organoid Model

Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Prevent Chronic Allergic Airway Inflammation Via TGF-β1-Smad2/Smad3 Signaling Pathway in Mice.

Modeling of lung phenotype of Hermansky–Pudlak syndrome type I using patient-specific iPSCs

Differentiation and on axon-guidance chip culture of human pluripotent stem cell-derived peripheral cholinergic neurons for airway neurobiology studies